Custom production of nanobodies or nanobody libraries to purified proteins.
Single domain antibodies (nanobodies) are increasingly becoming popular as reagents for research, for use as therapeutics, and as reagents for diagnostics. This is due, in large part, to their small size, stability, high affinity, high specificity, ease of manipulation, and ease of production.
The next production run is set to start November of 2021 and will take 3-4 months.
|Name:||Recombinant Nanobody Production Service|
|Source:||The nanobodies are initially identified utilizing alpaca, and are then produced in and purified from E. coli|
|Purification Method:||Affinity purification and molecular sieve chromatography|
|Method Used to Determine Concentration:||OD280 or Bradford Assay|
To produce a nanobody to your protein, we require:
Upon completion, we will provide:
If you publish research with this product, please let us know so we can cite your paper.